The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside
- 1 July 2014
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 17 (3) , 37-50
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral SuspensionAntimicrobial Agents and Chemotherapy, 2012
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteersJournal of Antimicrobial Chemotherapy, 2012
- Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to PosaconazoleAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal TherapyThe Journal of Infectious Diseases, 2011
- Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated AspergillosisAntimicrobial Agents and Chemotherapy, 2010
- Azole Binding Properties of Candida albicans Sterol 14-α Demethylase (CaCYP51)Antimicrobial Agents and Chemotherapy, 2010
- Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-α Demethylase (CYP51) Isoenzymes A and BAntimicrobial Agents and Chemotherapy, 2010
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida , Aspergillus , Fusarium , and Scedosporium SpeciesAntimicrobial Agents and Chemotherapy, 2008